The 13 linked references in paper И. Явелов С., И. Явелов С. (2013) “АНТИТРОМБОТИЧЕСКИЕ ПРЕПАРАТЫ В ПРОФИЛАКТИКЕ ТРОМБОТИЧЕСКИХ И ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ ПОСЛЕ ОСТРОГО КОРОНАРНОГО СИНДРОМА” / spz:neicon:aterotromboz:y:2013:i:1:p:82-104

  1. Fox Keith. A.A., Carruthers K.F., Dunbar D.R., et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK–Belgian Study) // Eur. Heart J. 2010. doi:10.1093/eurheartj/ehq326.
  2. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines // JACC. 2013. 61. doi:10.1016/j. jacc.2012.11.019.
  3. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) // Eur. Heart J. 2012. doi:10.1093/eurheartj/ehs215.
  4. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association // Eur. Heart J. 2012. doi:10.1093/eurheartj/ehs253.
  5. The ACTIVE Investigators. Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation // N. Engl. J. Med. 2009. doi: 10.1056/ NEJMoa0901301. (the paper at Socionet)
  6. Amin A.P., Bachuwar A., Reid K.J., et al. Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status // JACC. 2013. doi: 10.1016/j. jacc.2013.02.044.
  7. Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) // Eur. Heart J. 2012. doi:10.1093/ eurheartj/ehs109.
  8. Dewilde W.J.M., Oirbans T., Verheugt F.W.A., et al., for the WOEST study investigators Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial // Lancet. 2013. URL:http://dx.doi. org/10.1016/S0140-6736(12)62177-1.
  9. Mega J.L., Braunwald E., Wiviott S.D., et al., for the ATLAS ACS 2–TIMI 51 Investigators. Rivaroxaban in Patients with a Recent Acute Coronary Syndrome // N. Engl. J. Med. 2011. doi: 10.1056/ NEJMoa1112277.
  10. URL:http://www.clinicaltrials.gov/ct2/show/N CT00776633?term=ISAR&recr=Open&rank=9.
  11. Sarafoff N., Martischnig A., Wealer J., et al. Triple therapy with aspirin, prasugrel and vitamin K antagonists in patients with drug eluting stent implantation and an indication for oral anticoagulation // JACC. 2013. doi: 10.1016/j. jacc.2013.02.036.
  12. URL:http://www.accessdata.fda.gov/scripts/ cder/drugsatfda/index.cfm?fuseaction=Search. Label_ApprovalHistory#labelinfo.
  13. Oldgren J., Wallentin L., Alexander J.H., et al. New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis // Eur. Heart. J. 2013. doi:10.1093/eurheartj/ eht049.